REAP Financial Group’s Eli Lilly LLY Stock Holding History

REAP Financial Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$463K	Buy	504 +8	+2%	+$8.11K	0.09%	74
2025 Q4	$533K	Buy	496 +261	+111%	+$250K	0.11%	68
2025 Q3	$179K	Sell	235 -12	-5%	-$8.93K	0.04%	121
2025 Q2	$192K	Buy	247 +107	+76%	+$83.1K	0.05%	117
2025 Q1	$115K	Buy	140 +31	+28%	+$25.8K	0.03%	141
2024 Q4	$84.4K	Sell	109 -36	-25%	-$29.8K	0.02%	172
2024 Q3	$128K	Buy	145 +98	+209%	+$88.1K	0.03%	141
2024 Q2	$42.3K	Buy	47 +1	+2%	+$800	0.01%	202
2024 Q1	$35.5K	Buy	46 +5	+12%	+$3.56K	0.01%	226
2023 Q4	$23.7K	Buy	+41	New	+$23.9K	0.01%	317

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

REAP Financial Group's LLY Position: Q1 2026 in Review

REAP Financial Group increased its Eli Lilly (LLY) stake by 1.6% in Q1 2026, buying an estimated $8.11K and bringing the position to 504 shares worth $463K. The position accounts for 0.09% of the portfolio, ranked #74.

REAP Financial Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $533K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

REAP Financial Group held 504 shares of Eli Lilly worth $463K as of Q1 2026.
REAP Financial Group bought 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
Eli Lilly made up 0.09% of REAP Financial Group's portfolio in Q1 2026, its #74 holding.
REAP Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
REAP Financial Group's Eli Lilly position peaked at $533K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on REAP Financial Group's 13F filing for Q1 2026, filed 11 May 2026.